Hou, S.-M.; Cheng, C.-Y.; Chen, W.-L.; Chang, E.-M.; Lin, C.-Y.
NGF-TrkA Axis Enhances PDGF-C-Mediated Angiogenesis in Osteosarcoma via miR-29b-3p Suppression: A Potential Therapeutic Strategy Using Larotrectinib. Life 2025, 15, 99.
https://doi.org/10.3390/life15010099
AMA Style
Hou S-M, Cheng C-Y, Chen W-L, Chang E-M, Lin C-Y.
NGF-TrkA Axis Enhances PDGF-C-Mediated Angiogenesis in Osteosarcoma via miR-29b-3p Suppression: A Potential Therapeutic Strategy Using Larotrectinib. Life. 2025; 15(1):99.
https://doi.org/10.3390/life15010099
Chicago/Turabian Style
Hou, Sheng-Mou, Ching-Yuan Cheng, Wei-Li Chen, En-Ming Chang, and Chih-Yang Lin.
2025. "NGF-TrkA Axis Enhances PDGF-C-Mediated Angiogenesis in Osteosarcoma via miR-29b-3p Suppression: A Potential Therapeutic Strategy Using Larotrectinib" Life 15, no. 1: 99.
https://doi.org/10.3390/life15010099
APA Style
Hou, S.-M., Cheng, C.-Y., Chen, W.-L., Chang, E.-M., & Lin, C.-Y.
(2025). NGF-TrkA Axis Enhances PDGF-C-Mediated Angiogenesis in Osteosarcoma via miR-29b-3p Suppression: A Potential Therapeutic Strategy Using Larotrectinib. Life, 15(1), 99.
https://doi.org/10.3390/life15010099